{"id":661942,"date":"2026-10-30T12:53:57","date_gmt":"2026-10-30T11:53:57","guid":{"rendered":"https:\/\/aivancity.ai\/blog\/with-claude-a-new-milestone-for-biological-research\/"},"modified":"2026-10-30T12:55:18","modified_gmt":"2026-10-30T11:55:18","slug":"with-claude-a-new-milestone-for-biological-research","status":"publish","type":"post","link":"https:\/\/aivancity.ai\/blog\/en\/with-claude-a-new-milestone-for-biological-research\/","title":{"rendered":"With Claude, a new milestone for biological research?"},"content":{"rendered":"\n
\n

\n On September 23, 2026<\/strong>,\n Anthropic<\/strong>\n presented the initial findings from its\n AI-assisted biology lab<\/strong>.\n The company claims that a\n set of Claude agents<\/strong> identified,\n in genomic data<\/strong>,\n a system combining a\n reverse transcriptase<\/strong> to\n DNA repeats<\/strong> that are reminiscent of certain\n features of CRISPR<\/strong>.\n The result is interesting, but its\n biological function<\/strong>, its\n exact novelty<\/strong>, and its\n usefulness remain to be established<\/strong>:\n What does\n this experiment actually demonstrate about AI\u2019s ability to accelerate\n scientific discovery?<\/strong>\n <\/p>\n<\/div>\n\n

\n\n
\n 01\n <\/div>\n\n

\nWhat Anthropic Actually Announced\n <\/h2> \n\n<\/div>\n\n

In the spring of 2026, Anthropic established a life sciences research team and an experimental laboratory in the San Francisco Bay Area. Its goal is to use Claude to explore biological databases, generate hypotheses, and then test those hypotheses through laboratory experiments.[1]<\/a><\/sup><\/p>\n\n

For its first publicly announced program, the company asked Claude to search for unusual examples of reverse transcriptases. These enzymes copy RNA into DNA and play a role in several biological mechanisms. The researchers identified a complex comprising a reverse transcriptase, a long series of noncoding DNA repeats, and a neighboring protein whose function remains unknown. Anthropic named this complex ART, short for array-associated reverse transcriptases.[1<\/a>][2]<\/a><\/sup><\/p>\n\n

The system has been observed in bacteriophages, viruses that infect bacteria. The comparison with CRISPR stems primarily from the repetitive organization of the sequences and the presence of an associated enzymatic system. Anthropic notes, however, that it does not know the primary function of ART. It is therefore not established that it is a gene-editing mechanism, nor that it could become a medical tool.<\/p>\n\n

\n\n
\n 02\n <\/div>\n\n

\nWhat’s Really New\n <\/h2> \n\n<\/div>\n\n

The reverse transcriptase identified in the phage in question was not entirely unknown. It had already appeared in a comparative genomics study published in 2021 on three giant bacteriophages infecting Staphylococcus aureus. [7]<\/a><\/sup> The contribution attributed to Claude consists rather in having linked this enzyme to a larger structure, including DNA repeats and an accessory gene.<\/p>\n\n

The potential scientific novelty therefore lies in the characterization of a genetic system that has been little studied to date. The methodological novelty seems more clear-cut: general-purpose agents\u2014capable of writing code, querying databases, and reorienting their search\u2014have explored a data space that a human team would have found difficult to examine exhaustively within the same timeframe.<\/p>\n\n

This distinction is essential. Discovering that an element exists, proposing a function for it, demonstrating its mechanism, and transforming that mechanism into a tool are four distinct steps. At this stage, ART is primarily a promising biological subject for study.<\/p>\n\n